MiR-125b, miR-100 and miR-99a co-regulate vincristine resistance in childhood acute lymphoblastic leukemia.

[1]  Wei Xu,et al.  Distinctive microRNA signature is associated with the diagnosis and prognosis of acute leukemia , 2012, Medical Oncology.

[2]  A. Borkhardt,et al.  MiR-125 in normal and malignant hematopoiesis , 2012, Leukemia.

[3]  M. R. Hough,et al.  The miR-17-92 cluster expands multipotent hematopoietic progenitors whereas imbalanced expression of its individual oncogenic miRNAs promotes leukemia in mice. , 2012, Blood.

[4]  Si-yong Huang,et al.  miR-153 sensitized the K562 cells to As2O3-induced apoptosis , 2012, Medical Oncology.

[5]  Bo W. Han,et al.  Down-regulated miR-331–5p and miR-27a are associated with chemotherapy resistance and relapse in leukaemia , 2011, Journal of cellular and molecular medicine.

[6]  Ling Xu,et al.  A set of miRNAs that involve in the pathways of drug resistance and leukemic stem-cell differentiation is associated with the risk of relapse and glucocorticoid response in childhood ALL , 2011, Human molecular genetics.

[7]  J. Lieberman,et al.  Conserved Regulation of p53 Network Dosage by MicroRNA–125b Occurs through Evolving miRNA–Target Gene Pairs , 2011, PLoS genetics.

[8]  Hua Zhang,et al.  Upregulation of microRNA-125b contributes to leukemogenesis and increases drug resistance in pediatric acute promyelocytic leukemia , 2011, Molecular Cancer.

[9]  M. D. Boer,et al.  Discovery of new microRNAs by small RNAome deep sequencing in childhood acute lymphoblastic leukemia , 2011, Leukemia.

[10]  Y. You,et al.  MicroRNA-125b-2 confers human glioblastoma stem cells resistance to temozolomide through the mitochondrial pathway of apoptosis. , 2011, International journal of oncology.

[11]  Gang Chen,et al.  miR-125b confers resistance of ovarian cancer cells to cisplatin by targeting pro-apoptotic Bcl-2 antagonist killer 1 , 2011, Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban.

[12]  Y Enomoto,et al.  Eμ/miR-125b transgenic mice develop lethal B-cell malignancies , 2011, Leukemia.

[13]  R. Agami,et al.  MiRNA-27a controls FBW7/hCDC4-dependent cyclin E degradation and cell cycle progression , 2011, Cell cycle.

[14]  Caifu Chen,et al.  MicroRNA characterize genetic diversity and drug resistance in pediatric acute lymphoblastic leukemia , 2011, Haematologica.

[15]  Debashis Sahoo,et al.  MicroRNA-125b expands hematopoietic stem cells and enriches for the lymphoid-balanced and lymphoid-biased subsets , 2010, Proceedings of the National Academy of Sciences.

[16]  V. Thayanithy,et al.  Regulation of Heme Oxygenase-1 Protein Expression by miR-377 in Combination with miR-217* , 2010, The Journal of Biological Chemistry.

[17]  Beiyan Zhou,et al.  MicroRNA miR-125b causes leukemia , 2010, Proceedings of the National Academy of Sciences.

[18]  J. Fei,et al.  Anti-miR-21 oligonucleotide enhances chemosensitivity of leukemic HL60 cells to arabinosylcytosine by inducing apoptosis , 2010, Hematology.

[19]  Aadel A. Chaudhuri,et al.  MicroRNAs enriched in hematopoietic stem cells differentially regulate long-term hematopoietic output , 2010, Proceedings of the National Academy of Sciences.

[20]  Wei Xiong,et al.  MicroRNA-125b Confers the Resistance of Breast Cancer Cells to Paclitaxel through Suppression of Pro-apoptotic Bcl-2 Antagonist Killer 1 (Bak1) Expression* , 2010, The Journal of Biological Chemistry.

[21]  Xianghuo He,et al.  Multiple microRNAs modulate p21Cip1/Waf1 expression by directly targeting its 3′ untranslated region , 2010, Oncogene.

[22]  S. Armstrong,et al.  A novel mutation in the miR-128b gene reduces miRNA processing and leads to glucocorticoid resistance of MLL-AF4 Acute Lymphocytic Leukemia cells , 2010, Cell cycle.

[23]  S. Orkin,et al.  miR-125b-2 is a potential oncomiR on human chromosome 21 in megakaryoblastic leukemia. , 2010, Genes & development.

[24]  Epaminondas Doxakis,et al.  Post-transcriptional Regulation of α-Synuclein Expression by mir-7 and mir-153 , 2010, The Journal of Biological Chemistry.

[25]  Francesca Meloni,et al.  An emerging player in the adaptive immune response: microRNA-146a is a modulator of IL-2 expression and activation-induced cell death in T lymphocytes. , 2010, Blood.

[26]  M. Davis,et al.  An endogenous positively selecting peptide enhances mature T cell responses and becomes an autoantigen in the absence of microRNA miR-181a , 2009, Nature Immunology.

[27]  Oliver Hofmann,et al.  miR-24 Inhibits cell proliferation by targeting E2F2, MYC, and other cell-cycle genes via binding to "seedless" 3'UTR microRNA recognition elements. , 2009, Molecular cell.

[28]  C. Burge,et al.  Most mammalian mRNAs are conserved targets of microRNAs. , 2008, Genome research.

[29]  Dominique Leroux,et al.  Myeloid cell differentiation arrest by miR-125b-1 in myelodysplasic syndrome and acute myeloid leukemia with the t(2;11)(p21;q23) translocation , 2008, The Journal of experimental medicine.

[30]  Christina Thaller,et al.  miR-19, miR-101 and miR-130 co-regulate ATXN1 levels to potentially modulate SCA1 pathogenesis , 2008, Nature Neuroscience.

[31]  Jae Hoon Kim,et al.  MicroRNA Expression Profiles in Serous Ovarian Carcinoma , 2008, Clinical Cancer Research.

[32]  Rudolf Jaenisch,et al.  Targeted Deletion Reveals Essential and Overlapping Functions of the miR-17∼92 Family of miRNA Clusters , 2008, Cell.

[33]  N. Field,et al.  vFLIP from KSHV inhibits anoikis of primary endothelial cells , 2008, Journal of Cell Science.

[34]  J. Steitz,et al.  Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5′ UTR as in the 3′ UTR , 2007, Proceedings of the National Academy of Sciences.

[35]  C. Croce,et al.  miR-15 and miR-16 induce apoptosis by targeting BCL2. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[36]  Cheng Cheng,et al.  Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment. , 2004, The New England journal of medicine.

[37]  R. Pieters,et al.  TEL/AML1 gene fusion is related to in vitro drug sensitivity for L-asparaginase in childhood acute lymphoblastic leukemia. , 2000, Blood.

[38]  G. Ruvkun,et al.  Negative regulatory sequences in the lin-14 3'-untranslated region are necessary to generate a temporal switch during Caenorhabditis elegans development. , 1991, Genes & development.

[39]  Hong-zhao Li,et al.  Differential miRNA expression profiles in bladder urothelial carcinomas. , 2010, Asian Pacific journal of cancer prevention : APJCP.

[40]  W. Xiong,et al.  MICRORNA-125 B CONFERS THE RESISTANCE OF BREAST CANCER CELLS TO PACLITAXEL THROUGH SUPRESSION OF PRO-APOPTOTIC BCL-2 ANTAGONIST KILLER 1 ( BAK 1 ) EXPRESSION , 2010 .

[41]  Marina Bousqueta,et al.  MicroRNA miR-125 b causes leukemia , 2010 .

[42]  Noam Shomron,et al.  Hsa-mir-125b-2 is highly expressed in childhood ETV6/RUNX1 (TEL/AML1) leukemias and confers survival advantage to growth inhibitory signals independent of p53 , 2009, Leukemia.